Ardent Health, Inc. (ARDT) is a publicly traded Healthcare sector company. As of May 21, 2026, ARDT trades at $9.45 with a market cap of $1.45B and a P/E ratio of 9.87. ARDT moved -3.57% today. Year to date, ARDT is +5.70%; over the trailing twelve months it is -37.54%. Its 52-week range spans $8.07 to $20.72. Analyst consensus is buy with an average price target of $12.59. Rallies surfaces ARDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ardent Health Raises IMPACT Savings Target to $55M After 9% EBITDA Growth: Ardent posted Q4 revenue of $1.61 billion, flat year-over-year (3% ex-New Mexico DPP benefit), and adjusted EBITDA of $134 million, topping guidance midpoint by 2%. Full-year 2025 revenue rose 6% to $6.3 billion and adjusted EBITDA climbed 9% to $545 million, while IMPACT program savings guidance was raised to $55 million.
| Metric | Value |
|---|---|
| Price | $9.45 |
| Market Cap | $1.45B |
| P/E Ratio | 9.87 |
| EPS | $0.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.72 |
| 52-Week Low | $8.07 |
| Volume | 10 |
| Avg Volume | 0 |
| Revenue (TTM) | $6.32B |
| Net Income | $230.13M |
| Gross Margin | 0.00% |
10 analysts cover ARDT: 0 strong buy, 6 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.59.